Table 1.

Indicators of the immune status in patients with chronic respiratory diseases, mean ± SE

Indicators	Healthy subjects n = 10	Patient with chronic bronchitis, n = 15	Patients with chronic obstructive pulmonary disease n = 15
PAN, %	64.52 ± 0.68	59.90 ± 0.88*	57.52 ± 1.96*
TNFα, pg/ml	2.60 ± 0.03	7.89 ± 1.47***	×4.3 ± 0.3***
sTNF-RI, pg/ml	789.1 ± 7.10	1595.58 ± 141.53***	1523.4 ± 11.0***
bFGF, pg/ml	38.3 ± 0.8	38.93 ± 1.54	×53.9 ± 0.3***
TGF-β, pg/ml	1865.4 ± 11.3	1479.17 ± 19.60**	×48145.0 ± 20.6***
IL-8, pg/ml	11.5 ± 1.9	17.40 ± 1.20***	×13.4 ± 1.6

PAN – phagocytic activity of the neutrophils. Asteriks indicate significant differences of indicators between patients with respiratory diseases and healthy subjects: * for р < 0.05; ** for р < 0.01; *** for р < 0.001. Asteriks indicate significant differences of fatty acid contents between patients with chronic bronchitis and with chronic obstructive pulmonary disease: ^× for р < 0.001.